Company snapshot
Market Cap
$58B
Large-cap2016 — today
10-Year Price
+235%
2016 — today
52-Week Range
$164.47$257.55
Current $244.76· 86%
Featured in rankings
S&P500Dividend AristocratsMost Undervalued Healthcare StocksBest Healthcare Dividend StocksMost Undervalued Value StocksMost Undervalued Dividend StocksMost Undervalued Growth StocksCheapest Large-Cap Stocks
Rankings recomputed after each US market close — see where CAH stands against peers.
Similar companies
| Company | P/E | Div yield |
|---|---|---|
| ARGXargenx SE | 22.1 | — |
| NTRANatera, Inc. | -312.1 | — |
| BDXBecton, Dickinson and Company | 58.8 | 2.0% |
| CORCencora, Inc. | 24.1 | 0.7% |
| BSXBoston Scientific Corporation | 17.2 | — |
| EWEdwards Lifesciences Corporation | 52.7 | — |
| TAKTakeda Pharmaceutical Company Limited | 56.2 | 3.5% |
| AAgilent Technologies, Inc. | 35.7 | 0.4% |
Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.
Valuation in context
P/E ratio
33.9
Historically pricey
Historically pricey — last 10 years
Sector median 24.1above sector
P/B ratio
-21.3
N/A
Not meaningful — company is unprofitable
Sector median 2.3below sector
EV / EBITDA
18.1
Historically pricey
Historically pricey — last 10 years
Sector median 15.0above sector
Dividend Yield
0.8%
Near historic low
Near historic low — last 10 years
Sector median 1.9%below sector
PEG ratio
2.5
Above average
Pricier than usual over the last 10 years
Sector median 1.7above sector
FCF Yield
7.8%
Below average
Below the 10-year average
Sector median -12.4%above sector